Module

Hepatitis B Virus Resistance for Clinicians

Source: Hepatitis Annual Update 2006

Hepatitis B Virus Resistance for Clinicians

Program Director: Emmet B. Keeffe, MD, MACP

Faculty:

Anna S. F. Lok, MD

CME CREDIT INFORMATION

Release Date: 08/04/06

Expiration Date: 08/03/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.3 Nursing CE credits

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the methods used to detect antiviral-resistant forms of HBV
Review ways to prevent the development of antiviral-resistant HBV
Discuss the management of antiviral-resistant HBV

Topics covered include:

Introduction
Why Do Antiviral-Resistant HBV Mutants Arise?
Identifying Resistance Mutations
Rates of Genotypic Resistance to HBV Nucleos(t)ide Analogue Therapies
Detection, Prevention, and Consequences of Antiviral-Resistant HBV
Containment of Antiviral-Resistant HBV
Conclusions and Summary

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.